Genocea Biosciences, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Cambridge MA United States (2006)

Organization Overview

First Clinical Trial
2012
NCT01667341
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Genocea Biosciences, Inc.